Literature DB >> 30158125

Bacterial Lipoproteins Constitute the TLR2-Stimulating Activity of Serum Amyloid A.

Edward J Burgess1,2,3, Laura R Hoyt1,3, Matthew J Randall1,3, Madeleine M Mank1,3, Joseph J Bivona1,2,3, Philip L Eisenhauer4, Jason W Botten1,2,4,5, Bryan A Ballif6, Ying-Wai Lam6, Matthew J Wargo1,2,5, Jonathan E Boyson1,2,7, Jennifer L Ather1,3, Matthew E Poynter8,2,3.   

Abstract

Studies comparing endogenous and recombinant serum amyloid A (SAA) have generated conflicting data on the proinflammatory function of these proteins. In exploring this discrepancy, we found that in contrast to commercially sourced recombinant human SAA1 (hSAA1) proteins produced in Escherichia coli, hSAA1 produced from eukaryotic cells did not promote proinflammatory cytokine production from human or mouse cells, induce Th17 differentiation, or stimulate TLR2. Proteomic analysis of E. coli-derived hSAA1 revealed the presence of numerous bacterial proteins, with several being reported or probable lipoproteins. Treatment of hSAA1 with lipoprotein lipase or addition of a lipopeptide to eukaryotic cell-derived hSAA1 inhibited or induced the production of TNF-α from macrophages, respectively. Our results suggest that a function of SAA is in the binding of TLR2-stimulating bacterial proteins, including lipoproteins, and demand that future studies of SAA employ a recombinant protein derived from eukaryotic cells.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30158125      PMCID: PMC6179936          DOI: 10.4049/jimmunol.1800503

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.

Authors:  Mingjie Chen; Huibing Zhou; Ni Cheng; Feng Qian; Richard D Ye
Journal:  Immunobiology       Date:  2014-08-10       Impact factor: 3.144

2.  SAA does not induce cytokine production in physiological conditions.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Nancy R Webb; Frederick C de Beer
Journal:  Cytokine       Date:  2012-11-17       Impact factor: 3.861

3.  Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway.

Authors:  Lei Sun; Ziyan Zhu; Ni Cheng; Qian Yan; Richard D Ye
Journal:  Eur J Immunol       Date:  2014-05-22       Impact factor: 5.532

4.  Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.

Authors:  Rong L He; Jian Zhou; Crystal Z Hanson; Jia Chen; Ni Cheng; Richard D Ye
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

5.  Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A.

Authors:  Ni Cheng; Rong He; Jun Tian; Patrick P Ye; Richard D Ye
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

6.  A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2).

Authors:  D M Steel; G C Sellar; C M Uhlar; S Simon; F C DeBeer; A S Whitehead
Journal:  Genomics       Date:  1993-05       Impact factor: 5.736

7.  Domain enhanced lookup time accelerated BLAST.

Authors:  Grzegorz M Boratyn; Alejandro A Schäffer; Richa Agarwala; Stephen F Altschul; David J Lipman; Thomas L Madden
Journal:  Biol Direct       Date:  2012-04-17       Impact factor: 4.540

8.  Serum Amyloid A Induces Toll-Like Receptor 2-Dependent Inflammatory Cytokine Expression and Atrophy in C2C12 Skeletal Muscle Myotubes.

Authors:  Samantha L Passey; Steven Bozinovski; Ross Vlahos; Gary P Anderson; Michelle J Hansen
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

9.  Serum Amyloid A Promotes E-Selectin Expression via Toll-Like Receptor 2 in Human Aortic Endothelial Cells.

Authors:  Eisaku Nishida; Makoto Aino; Shu-Ichiro Kobayashi; Kosuke Okada; Tasuku Ohno; Takeshi Kikuchi; Jun-Ichiro Hayashi; Genta Yamamoto; Yoshiaki Hasegawa; Akio Mitani
Journal:  Mediators Inflamm       Date:  2016-10-05       Impact factor: 4.711

10.  Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix.

Authors:  Stephanie E Seidl; Lawrence G Pessolano; Christopher A Bishop; Michael Best; Celeste B Rich; Phillip J Stone; Barbara M Schreiber
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

View more
  11 in total

Review 1.  Role of serum amyloid A in atherosclerosis.

Authors:  Preetha Shridas; Lisa R Tannock
Journal:  Curr Opin Lipidol       Date:  2019-08       Impact factor: 4.776

2.  [Association of rs4638289 and rs7131332 polymorphisms of the serum amyloid A1 gene with Kawasaki disease].

Authors:  Ying Chen; Cheng Wang; Qing Ji; Juan Zhang; Cheng Tan; Shuang-Shuang Wang; Xiu-Ying Yi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-06

Review 3.  The turning away of serum amyloid A biological activities and receptor usage.

Authors:  Sara Abouelasrar Salama; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Immunology       Date:  2021-01-04       Impact factor: 7.215

4.  Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1.

Authors:  Sara Abouelasrar Salama; Mirre De Bondt; Mieke De Buck; Nele Berghmans; Paul Proost; Vivian Louise Soares Oliveira; Flavio A Amaral; Mieke Gouwy; Jo Van Damme; Sofie Struyf
Journal:  Front Immunol       Date:  2020-05-14       Impact factor: 7.561

5.  Serum Amyloid A3 is required for normal lung development and survival following influenza infection.

Authors:  Jennifer L Ather; Oliver Dienz; Jonathan E Boyson; Vikas Anathy; Eyal Amiel; Matthew E Poynter
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

6.  Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet.

Authors:  Belal Chami; Farjaneh Hossain; Thomas W Hambly; Xiaoping Cai; Roshanak Aran; Genevieve Fong; Abigail Vellajo; Nathan J J Martin; XiaoSuo Wang; Joanne M Dennis; Arpeeta Sharma; Waled A Shihata; Jaye P F Chin-Dusting; Judy B de Haan; Alexandra Sharland; Carolyn L Geczy; Ben Freedman; Paul K Witting
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

Review 7.  High-Density Lipoproteins and Serum Amyloid A (SAA).

Authors:  Nancy R Webb
Journal:  Curr Atheroscler Rep       Date:  2021-01-15       Impact factor: 5.113

8.  Serum amyloid A is a positive acute phase protein in Russian sturgeon challenged with Aeromonas hydrophila.

Authors:  Mauricio Castellano; Valeria Silva-Álvarez; Marcio Aversa-Marnai; María Lamas-Bervejillo; Ignacio Quartiani; Alejandro Perretta; Andrea Villarino; Ana María Ferreira
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

9.  Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case.

Authors:  Sara Abouelasrar Salama; Mirre De Bondt; Nele Berghmans; Mieke Gouwy; Vivian Louise Soares de Oliveira; Sergio C Oliveira; Flavio A Amaral; Paul Proost; Jo Van Damme; Sofie Struyf; Mieke De Buck
Journal:  Mediators Inflamm       Date:  2020-07-06       Impact factor: 4.711

Review 10.  Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve.

Authors:  Olga Gursky
Journal:  Curr Atheroscler Rep       Date:  2020-09-24       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.